Erica A. Voss

968 total citations
27 papers, 500 citations indexed

About

Erica A. Voss is a scholar working on Epidemiology, Oncology and Economics and Econometrics. According to data from OpenAlex, Erica A. Voss has authored 27 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Oncology and 5 papers in Economics and Econometrics. Recurrent topics in Erica A. Voss's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Chronic Disease Management Strategies (3 papers) and Health, Environment, Cognitive Aging (3 papers). Erica A. Voss is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Chronic Disease Management Strategies (3 papers) and Health, Environment, Cognitive Aging (3 papers). Erica A. Voss collaborates with scholars based in United States, Netherlands and United Kingdom. Erica A. Voss's co-authors include Patrick Ryan, Martijn J. Schuemie, Qianli Ma, Frank DeFalco, Vivienne J. Zhu, Rupa Makadia, Chris Knoll, Ajit Londhe, Amy Matcho and Richard D. Boyce and has published in prestigious journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and BMC Public Health.

In The Last Decade

Erica A. Voss

24 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica A. Voss United States 11 88 76 75 60 51 27 500
Guillaume Bouzillé France 18 70 0.8× 78 1.0× 136 1.8× 79 1.3× 86 1.7× 86 793
Robert Eriksson Denmark 11 138 1.6× 142 1.9× 137 1.8× 65 1.1× 37 0.7× 22 581
Rupa Makadia United States 7 116 1.3× 123 1.6× 62 0.8× 69 1.1× 85 1.7× 12 598
James D. Cowan United States 9 179 2.0× 102 1.3× 41 0.5× 93 1.6× 64 1.3× 12 739
Suehyun Lee South Korea 11 44 0.5× 38 0.5× 58 0.8× 30 0.5× 86 1.7× 47 603
Jason M. Baron United States 16 103 1.2× 197 2.6× 74 1.0× 156 2.6× 66 1.3× 56 874
Shelley A. Rusincovitch United States 9 94 1.1× 104 1.4× 95 1.3× 127 2.1× 29 0.6× 14 451
Chih‐Wei Huang Taiwan 17 86 1.0× 82 1.1× 73 1.0× 45 0.8× 97 1.9× 51 580
Monica M. Horvath United States 14 179 2.0× 52 0.7× 70 0.9× 151 2.5× 99 1.9× 26 731
Phung‐Anh Nguyen Taiwan 16 64 0.7× 147 1.9× 174 2.3× 163 2.7× 74 1.5× 47 945

Countries citing papers authored by Erica A. Voss

Since Specialization
Citations

This map shows the geographic impact of Erica A. Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica A. Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica A. Voss more than expected).

Fields of papers citing papers by Erica A. Voss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica A. Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica A. Voss. The network helps show where Erica A. Voss may publish in the future.

Co-authorship network of co-authors of Erica A. Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Erica A. Voss. A scholar is included among the top collaborators of Erica A. Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica A. Voss. Erica A. Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blacketer, Clair, et al.. (2025). Advancing Real-World Evidence Through a Federated Health Data Network (EHDEN): Descriptive Study. Journal of Medical Internet Research. 27. e74119–e74119.
2.
Rao, Gowtham, Azza Shoaibi, Rupa Makadia, et al.. (2025). CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization. PLoS ONE. 20(1). e0310634–e0310634. 3 indexed citations
3.
Makadia, Rupa, Azza Shoaibi, Gowtham Rao, et al.. (2023). Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network. JAMIA Open. 6(4). ooad096–ooad096. 1 indexed citations
4.
Voss, Erica A., et al.. (2023). European Health Data & Evidence Network—learnings from building out a standardized international health data network. Journal of the American Medical Informatics Association. 31(1). 209–219. 12 indexed citations
5.
Raventós, Berta, Sergio Fernández‐Bertolín, María Aragón, et al.. (2023). Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research. Clinical Epidemiology. Volume 15. 969–986. 6 indexed citations
6.
Papež, Václav, Erica A. Voss, Elena Garcia Lara, et al.. (2022). Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. Journal of the American Medical Informatics Association. 30(1). 103–111. 27 indexed citations
7.
8.
Fife, Daniel, et al.. (2022). Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations. Neuropsychopharmacology Reports. 42(3). 347–351. 1 indexed citations
9.
Voss, Erica A., et al.. (2022). Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study. Drug Safety. 45(7). 791–807. 3 indexed citations
10.
Wang, Yi‐Ting, Rupa Makadia, Jill Hardin, et al.. (2021). Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration. BMC Gastroenterology. 21(1). 121–121. 1 indexed citations
11.
Voss, Erica A., et al.. (2021). Biologically Relevant Lighting: An Industry Perspective. Frontiers in Neuroscience. 15. 637221–637221. 9 indexed citations
12.
Blacketer, Clair, Erica A. Voss, Frank DeFalco, et al.. (2021). Using the Data Quality Dashboard to Improve the EHDEN Network. Applied Sciences. 11(24). 11920–11920. 12 indexed citations
13.
14.
Yuan, Žhong, Erica A. Voss, Frank DeFalco, et al.. (2017). Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study. Journal of Stroke and Cerebrovascular Diseases. 26(8). 1721–1731. 8 indexed citations
15.
Voss, Erica A., et al.. (2016). Accuracy of an automated knowledge base for identifying drug adverse reactions. Journal of Biomedical Informatics. 66. 72–81. 69 indexed citations
16.
Danese, Mark D., Erica A. Voss, Michelle Gleeson, et al.. (2015). Feasibility of Converting the Medicare Synthetic Public Use Data Into a Standardized Data Model for Clinical Research Informatics.. AMIA. 1 indexed citations
17.
Voss, Erica A., Qianli Ma, & Patrick Ryan. (2015). The impact of standardizing the definition of visits on the consistency of multi-database observational health research. BMC Medical Research Methodology. 15(1). 13–13. 22 indexed citations
18.
Voss, Erica A., Patrick Ryan, Paul Stang, David M. Hough, & Larry Alphs. (2015). Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics. International Clinical Psychopharmacology. 30(3). 151–157. 14 indexed citations
19.
Fife, Daniel, Vivienne J. Zhu, Erica A. Voss, Grace A. Levy-Clarke, & Patrick Ryan. (2014). Exposure to Oral Fluoroquinolones and the Risk of Retinal Detachment: Retrospective Analyses of Two Large Healthcare Databases. Drug Safety. 37(3). 171–182. 23 indexed citations
20.
Zimmermann, I., et al.. (1989). Controlled prospective study of oral amoxycillin/clavulanate vs ciprofloxacin in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 24(suppl B). 185–193. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillaume Bouzillé Breakdown of academic impact, for papers by Robert Eriksson Breakdown of academic impact, for papers by Rupa Makadia Breakdown of academic impact, for papers by James D. Cowan Breakdown of academic impact, for papers by Suehyun Lee Breakdown of academic impact, for papers by Jason M. Baron Breakdown of academic impact, for papers by Shelley A. Rusincovitch Breakdown of academic impact, for papers by Chih‐Wei Huang Breakdown of academic impact, for papers by Monica M. Horvath Breakdown of academic impact, for papers by Phung‐Anh Nguyen
Rankless by CCL
2026